Founded in 1847, Stiefel Laboratories is a privately held company and is the world's largest independent pharmaceutical company specializing in dermatology. The company manufactures and markets a variety of prescription and non-prescription dermatological products. Its wholly-owned global network is comprised of more than 30 subsidiaries, manufacturing plants in six countries, research and development facilities on four continents, and products marketed in more than 100 countries around the world. Stiefel Laboratories supplements its R&D efforts by seeking strategic partnerships and acquisitions around the world.

Company was acquired by GlaxoSmithKline Plc

Acquired Companies: Connetics Corp., Barrier Therapeutics Inc., Stiefel Research Institute